Viewing Study NCT05874193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-01-22 @ 4:02 PM
Study NCT ID: NCT05874193
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-21
First Post: 2023-04-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
Sponsor: Cristiana Costa Chase, DO
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed/refractory Multiple Myeloma View
None Belantamab Mafodotin View
None Blenrep View